Pipeline Molecules
Under Investigation
Sumitomo Pharma America, Inc. is advancing a portfolio of investigational therapies across multiple areas, including oncology, central nervous system (CNS), and regenerative medicine. Our research and development efforts focus on targeted small molecules and emerging modalities designed to address areas of unmet medical need.
Under Investigation
Across Various Phases
Open for Enrollment
No results match the selected filters.
Sumitomo Pharma America, Inc. may consider access to investigational products outside of clinical trials for eligible patients who have no alternative treatment options.
View Expanded Access ProgramFind a Medical Science Liaison (MSL) in your region and specialty.
Sign up to receive the latest clinical data, scientific resources and news from Sumitomo Pharma America Medical Affairs.
Our Medical Information team can help you find the information you need.
+1 (800) 739-0565Monday–Friday, 8 AM–8 PM ET
24 hours, 7 days a week
Please report any side effects related to any Sumitomo Pharma America, Inc. medication by contacting us. You may also contact the US Food and Drug Administration (FDA) directly by visiting www.fda.gov/Safety/MedWatch or calling 1-800-FDA-1088.